Aimmune Therapeutics to Present at the RBC Capital Markets 2020 Global Healthcare Conference May 12, 2020 08:00AM
Aimmune Therapeutics (AIMT) KOL Call Details the Palforzia Opportunity - RBC Capital Sep 12, 2019 06:37AM
Pre-Open 09/11: (TTOO) (LXRX) (LOVE) Higher (ZS) (GME) (PLAY) Lower (more...) Sep 11, 2019 09:16AM
Aimmune Therapeutics (AIMT) PT Lowered to $50 at RBC Capital Aug 9, 2019 07:00AM
Aimmune to Present at RBC Capital Markets Global Healthcare Conference May 16, 2019 08:30AM


Mar 26, 2019 06:27AM Aimmune Therapeutics (AIMT) PT Raised to $58 at RBC Capital
Mar 25, 2019 09:26AM Pre-Open Stock Movers 03/25: (CRIS) (AVYA) (AIMT) Higher; (PTI) (REPH) (AKAM) Lower (more...)
Dec 20, 2018 09:29AM Pre-Open Stock Movers 12/20: (AGEN) (TLRY) (PTE) Higher; (DBVT) (ADMA) (SPPI) Lower (more...)
Dec 20, 2018 07:02AM DBVT Setback Removes Competitive Risk for Aimmune Therapeutics' (AIMT) AR101 - RBC
Mar 9, 2018 08:09AM Aimmune Therapeutics (AIMT) Takeaways From Allergist KOL Call - RBC
Mar 2, 2018 04:01PM Aimmune Therapeutics Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock
Feb 26, 2018 04:01PM Aimmune Therapeutics Announces Closing of Public Offering of Common Stock
Feb 22, 2018 05:54AM Aimmune Therapeutics (AIMT) Prices 5.5M Share Common Offering at $32/Sh
Feb 21, 2018 07:28PM Aimmune Therapeutics Announces Pricing of Public Offering of Common Stock
Feb 20, 2018 04:47PM Aimmune Therapeutics (AIMT) Offers $150M in Common Equity
Feb 20, 2018 04:16PM Aimmune Therapeutics Announces Proposed Public Offering of Common Stock
Feb 7, 2018 05:13AM RBC Capital Starts Aimmune Therapeutics (AIMT) at Outperform